(Q51365910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Stromal-epithelial interactions modulate cross-talk between prolactin receptor and HER2/Neu in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Cong Xu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Wen Y Chen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

language of work or name

English

0 references

publication date

22 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

157-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-012-1954-3

21 January 2020

exact match

0 references

cites work

Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

PAK1-Nck regulates cyclin D1 promoter activity in response to prolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin-induced expression of vascular endothelial growth factor via Egr-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

The role of prolactin in mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Re-evaluation of the prolactin receptor expression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin regulation of estrogen receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Mechanistic aspects of crosstalk between GH and PRL and ErbB receptor family signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

The tumor microenvironment as a determinant of drug response and resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Rac1 links integrin-mediated adhesion to the control of lactational differentiation in mammary epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

A role for the cytoskeleton in prolactin-dependent mammary epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Prolactin receptor-integrin cross-talk mediated by SIRPα in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1954-3

10.1007/S10549-012-1954-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22270933%20AND%20SRC:MED&resulttype=core&format=json

release_wz3s6j52xff4rcrlc5vuhnbmqa

21 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wz3s6j52xff4rcrlc5vuhnbmqa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference